Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangzhou, China.
Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangzhou, China
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F689-F701. doi: 10.1152/ajprenal.00584.2016. Epub 2017 Jan 18.
White adipose tissue plays an important role in the development of metabolic disturbance, which is a common feature in patients with chronic kidney disease (CKD). The effect of CKD on white adipose tissue remains poorly appreciated. Here, we evaluated the inflammatory potential of visceral white adipose tissue in a rat model of CKD. The results showed that production of proinflammatory cytokines and infiltration of macrophage in the tissue were increased significantly in CKD rats compared with sham rats. Moreover, the primary adipocytes and stromal vascular fraction under the condition of CKD could trigger the inflammatory response in each other. Free fatty acid induced robust inflammatory response in ex vivo peritoneal-derived macrophages from CKD rats, which was associated with reduced activity of silent information regulator T1 (SIRT1). Improvement of SIRT1 activity by an activator could alleviate free fatty acid-induced inflammatory response in the macrophages and inflammation in the white adipose tissue. Moreover, oxidative stress occurred in the tissue and linked with the reduced activity of SIRT1 in macrophages and enhanced release of free fatty acid in the tissue. We thus identified CKD as a risk factor for chronic inflammation in white adipose tissue. These observations might open up new therapeutic strategies for metabolic disturbance in CKD via the modulation of adipose tissue-related pathways.
白色脂肪组织在代谢紊乱的发展中起着重要作用,而代谢紊乱是慢性肾脏病(CKD)患者的共同特征。CKD 对白色脂肪组织的影响仍未得到充分认识。在这里,我们评估了 CKD 大鼠模型中内脏白色脂肪组织的炎症潜力。结果表明,与假手术大鼠相比,CKD 大鼠组织中促炎细胞因子的产生和巨噬细胞的浸润显著增加。此外,在 CKD 条件下的原代脂肪细胞和基质血管部分能够相互引发炎症反应。来自 CKD 大鼠的腹膜衍生巨噬细胞在游离脂肪酸的刺激下会引发强烈的炎症反应,这与沉默信息调节因子 T1(SIRT1)活性降低有关。激活剂改善 SIRT1 活性可以减轻巨噬细胞中游离脂肪酸诱导的炎症反应和白色脂肪组织中的炎症。此外,组织中发生氧化应激,与巨噬细胞中 SIRT1 活性降低以及组织中游离脂肪酸释放增加有关。因此,我们将 CKD 确定为白色脂肪组织慢性炎症的危险因素。这些观察结果可能通过调节与脂肪组织相关的途径,为 CKD 中的代谢紊乱开辟新的治疗策略。